Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg

Name: Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg
Brand: CARE FORMULATION LABS PRIVATE LIMITED
Price: 82.0 INR
Availability: InStock

Price 82.0 INR/ Strip

Get a Price/Quote

MOQ : 100 Strips

Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg Specification

Pacakaging (Quantity Per Box)
10x10 tablet

Indication
This medication is used to treat seizure disorders, mental/mood conditions, and to prevent migraine headaches.

Salt Composition
Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg

Dosage Form
Tablet

Ingredients
Azathioprine (25 mg).

Physical Form
Tablets

Dosage Guidelines
Use as directed by a healthcare professional

About Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg

Description

Each Film Coated Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg

Doses

As Directed by physician

Indication

Valproic acid is used to treat bipolar disorder. It's occasionally used to prevent migraine headaches and can also be used to treat epilepsy.

Dual Active Ingredients for Enhanced Efficacy

This tablet unites two established compounds-Divalproex Sodium for neurological stabilization and Azathioprine for its immunosuppressive properties. This combination is engineered to offer clinical effectiveness in controlling seizures, managing certain mood disorders, and preventing migraines, making it a versatile option for healthcare providers and patients alike.

Controlled Release Technology

The extended-release formulation delivers the active ingredients steadily over time, minimizing peak-related side effects and reducing the frequency of dosing. This approach helps maintain a consistent therapeutic response, contributing to improved patient adherence and overall treatment outcomes.

Comprehensive Supply Chain Solutions

With flexible packaging (10x10 tablets per box) and a wide network covering dealer, distributor, exporter, manufacturer, and more, this product can be sourced easily throughout India. It is suitable for retail, wholesale, or institutional needs, ensuring reliable access for a diverse range of end users.

FAQ's of Extended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 250 mg:

Q: How should the extended-release tablet containing Divalproex Sodium and Azathioprine be taken?

A: It should be taken exactly as prescribed by your healthcare provider, usually once a day. Swallow the tablet whole without crushing or chewing, preferably at the same time each day to maintain consistent blood levels.

Q: What conditions is this medication indicated for?

A: This medication is primarily indicated for the management of seizure disorders, mood/mental health conditions such as bipolar disorder, and the prevention of migraine headaches, offering broad neurological benefits.

Q: When is it appropriate to start treatment with this combination tablet?

A: Doctors usually prescribe this tablet after a thorough medical evaluation if you have not responded adequately to other treatments for seizures or migraines, or if you require combined management of these conditions.

Q: Where can I obtain the extended-release tablet in India?

A: The tablet is available through authorized dealers, distributors, retailers, and pharmacies across India. It is offered in 10x10 tablet boxes and supplied by various manufacturers, wholesalers, and importers.

Q: What is the benefit of the extended-release formulation?

A: Extended-release technology allows for a steady release of medication into the bloodstream, reducing the risk of side effects and ensuring stable therapeutic effects, which can improve patient compliance and overall results.

Q: Are there specific dosage guidelines for this medication?

A: The dosage should be tailored by a healthcare professional based on your individual needs and response. Do not alter your dose without consulting your doctor.

Q: What precautions should I take while using this tablet?

A: Regular medical monitoring and follow-ups are necessary due to the potential effects of Divalproex Sodium and Azathioprine. Inform your doctor of any other medications or health conditions to avoid interactions or complications.

Tell us about your requirement